Argentarii, LLC Vera Therapeutics, Inc. Transaction History
Argentarii, LLC
- $307 Billion
- Q4 2025
A detailed history of Argentarii, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Argentarii, LLC holds 4,330 shares of VERA stock, worth $122,625. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,330Holding current value
$122,625% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
197Shares Held
65.9MCall Options Held
128KPut Options Held
172K-
Avoro Capital Advisors LLC New York, NY6.21MShares$176 Million2.46% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.03MShares$114 Million9.86% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.67MShares$104 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.64MShares$103 Million1.96% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$94.5 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $766M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...